TerraFlow

What TerraFlow does

TerraFlow (legally terraFlow Bioinformatics Corporation, formerly Daprar Corp dba terraFlow) is a private Delaware-incorporated SaaS company founded in 2019 that operates a cloud-based platform for automated flow cytometry and CyTOF data analysis. The platform ingests FCS files, applies machine learning and expert-informed models to gate every possible phenotype including rare subtypes, and performs exhaustive combinatorial analysis (equivalent to ~10,000 manual hours per dataset) with statistical comparison across user-defined sample groups. Its signature differentiator is literature mapping against a corpus of over one million publications that automatically links identified phenotypes to primary literature, producing publication-ready reports within 24 hours with traceable gating pathways for regulatory and reproducibility defensibility. The platform is offered via two parallel GTM motions: a sales-led enterprise motion with custom pricing and demo-led selling for pharma, biotech, CROs and academic medical centers; and a product-led self-serve experience at dash.terraflow.app where users upload, label, gate, and submit files directly. TerraFlow serves named reference customers including Memorial Sloan Kettering Cancer Center, Cleveland Clinic, the National Institutes of Health, Sylvester Comprehensive Cancer Center, and the University of Alabama at Birmingham. The company is SOC 2 Type II certified (with SOC 3 also referenced), was co-founded by CEO Arielle Ginsberg and CTO Dan Freeman (PhD, Harvard Medical School), operates with a 1-10 person team, and has not disclosed any external funding rounds or revenue figures in the available data.

Name

TerraFlow

Legal name

terraFlow Bioinformatics Corporation

Website

https://terraflow.app

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

TerraFlow is a cloud-based SaaS platform that automates flow cytometry and CyTOF data analysis, using machine learning to gate every phenotype and mapping results against a literature database to deliver publication-ready reports within 24 hours for academic, pharma, biotech, and CRO researchers.

Ownership category

akta.pro rank

Product category

Flow Cytometry Analysis Software

NAICS

Other Computer Related Services (541519), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

Keywords

• Flow cytometry analysis
• Immunophenotyping software
• Single-cell profiling
• Biomarker discovery
• High-dimensional data analysis

Headquarters

HQ city

Wilmington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. SaaS Platform Subscription: Cloud-based SaaS service providing cytometry data analysis. Custom pricing tailored to team size. Users upload FCS files and receive automated analysis reports.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

TerraFlow offers a cloud-based SaaS platform that ingests FCS flow cytometry files and produces automated, publication-ready analysis reports within 24 hours. The platform applies machine learning and expert-informed models to gate every possible phenotype (including rare subtypes), performs statistical comparisons across sample groups, and contextualizes results against more than 1 million scientific publications — eliminating the need for manual gating, custom coding, or in-house bioinformatics support.

Product overview

TerraFlow offers a single unified cloud-based SaaS platform for automated flow cytometry and CyTOF data analysis. The platform consists of three integrated workflow stages: Upload & Label (for data submission and sample grouping), Explore & Analyze (for automated phenotype discovery and statistical analysis), and Report & Contextualize (for literature-backed biological interpretation). Users upload FCS files and receive publication-ready reports within 24 hours, with every identified phenotype linked directly to primary literature. The platform combines machine learning-powered automated gating with human-in-the-loop controls and literature mapping capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• terraFlow Platform Cloud-based SaaS platform for automated flow cytometry and CyTOF data analysis covering upload-and-label, automated gating, statistical analysis, and literature-contextualized report generation; targeted at pharma, biotech, CRO, government, and academic research laboratories seeking publication-ready results in 24 hours without coding or in-house bioinformatics.

Quantifiable outcome

• Full immunophenotyping reports delivered within 24 hours
• +1 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature5 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• FlowJo (BD Biosciences): FlowJo is the de facto standard desktop and cloud flow cytometry analysis platform, owned by BD Biosciences. It directly overlaps with TerraFlow's core workflow (FCS file gating, immunophenotyping) but bundles with BD's installed base of flow instruments, giving it a much larger footprint and incumbency advantage in academic and pharma labs.
• Cytek Biosciences (SpectroFlo): Cytek sells spectral flow cytometry instruments and bundles SpectroFlo software for acquisition and analysis. It is a broad incumbent in the same high-dimensional flow cytometry workflow TerraFlow targets, with the advantage of tight instrument-software integration.
• 10x Genomics: 10x Genomics is a dominant single-cell analysis platform spanning scRNA-seq, immune profiling, and multi-omics with its own Loupe and Cell Ranger software. It is adjacent to TerraFlow's high-dimensional cell profiling workflow and is a key alternative destination for translational research budgets.
• QIAGEN Digital Insights (CLC): QIAGEN's CLC genomics workbench and related bioinformatics products cover a wide range of life-science data analysis including flow-derived and sequencing data. It competes for the same translational and pharma bioinformatics budget but as part of a much broader portfolio.

Direct peers

• Omiq: Omiq is a cloud-based, subscription SaaS for high-dimensional flow and CyTOF cytometry analysis built on the original Cytobank codebase. It is the closest direct competitor to TerraFlow in target customer, modality (flow/CyTOF), and cloud-delivered SaaS model, with overlapping features like auto-gating and statistical analysis.
• De Novo Software (FCS Express): FCS Express is a long-standing flow cytometry analysis platform sold via per-user licenses to academic and clinical labs. It competes with TerraFlow on the same core use case (FCS file analysis, immunophenotyping, reporting) and shares the same primary buyer persona.
• Partek Flow (Partek / Illumina): Partek Flow is a SaaS-style single-cell and flow cytometry analysis suite offering statistical and visualization workflows. It targets the same translational and pharma research buyer and overlaps with TerraFlow on high-dimensional cytometry and biomarker discovery use cases.

Emerging players

• Bioinformatics Solutions Inc. (SeqGeq): SeqGeq is a flow cytometry and single-cell analysis platform with graphical workflows and plug-in extensibility. It is a comparable niche SaaS in the same high-parameter cytometry analysis category, serving a mix of academic and translational users.
• CellProfiler (Broad Institute): CellProfiler is a widely used open-source image analysis platform that some groups repurpose for cell profiling. While primarily an image-cytometry tool rather than flow, it represents a free, expert-driven alternative that competes for the same researcher mindshare in cell phenotyping.
• Immunai: Immunai applies AI to immune profiling and high-dimensional cytometry/single-cell data for pharma R&D and clinical trial applications. It addresses an overlapping translational and pharma buyer with a more services- and data-centric model, representing an emerging alternative for AI-driven immune signature discovery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/terraflowbio

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TerraFlow